01—Abstract
Summary
Summary of the 10-K filed February 11, 2014. Cited figures are marked; the original filing is the authoritative source.
Omega Healthcare Investors, Inc. ("Omega") is a self-administered REIT that provides lease and mortgage financing primarily to operators of skilled nursing facilities (SNFs) in the United States.
As of December 31, 2013, its portfolio included 541 healthcare facilities in 38 states operated by 49 third-party operators, with gross investments of approximately $3.9 billiona. Total revenues rose to $418.7 million in 2013 from $350.5 million in 2012, and net income was $172.5 million compared with $120.7 million, while funds from operations available to common stockholders were $302.7 million versus $222.2 million. The main driver of 2013 growth was new investment, most notably a $529 million purchase/leaseback of 56 facilities operated by Ark Holding Company, Inc., closed in November 2013 and accounted for as direct financing leases yielding 10.6% per annum.
Omega also funded $33 millionb of acquisitions with existing operators, $35 million of capital expenditure investments, and a $25 million mezzanine loan that was repaid in December 2013. Financing was supported by a $170.4 million equity shelf program sale, an $84.6 million common stock offering in October 2013, and a new $200 million term loan entered in December 2013. Total debt was approximately $2.0 billion, representing about 60.9% of total capitalization.
Concentration and operator-risk disclosures are significant. New Ark Investment, Inc. represented 14%c of total investments, and Genesis HealthCare accounted for 13% of 2013 revenues, while CommuniCare represented 11%.
The filing also describes ongoing reimbursement pressure from Medicare and Medicaid, including the American Taxpayer Relief Act, which the filing says will reduce SNF payments by approximately $600 milliond from FY 2013 through FY 2022. The board declared a 2014 common dividend of $0.49 per share, up $0.01 from the prior quarter.
02—Key points
Key Highlights
- Total revenues of $418.7 million in 2013, up from $350.5 million in 2012; net income of $172.5 million versus $120.7 million.
- Funds from operations available to common stockholders of $302.7 million in 2013, compared with $222.2 million in 2012.
- Closed a $529 million purchase/leaseback of 56 facilities with Ark Holding in November 2013, with rent yielding 10.6% per annum under four 50-year direct financing leases.
- Portfolio of 541 facilities in 38 states operated by 49 operators, with gross investments of approximately $3.9 billion at December 31, 2013.
- Concentration risk: New Ark Investment, Inc. at 14% of total investments; Genesis HealthCare at 13% of 2013 revenues and CommuniCare at 11%.
- Total debt of approximately $2.0 billion, representing about 60.9% of total capitalization; a new $200 million term loan was fully drawn in January 2014.
- Common dividends paid totaled $1.86 per share in 2013, and the board declared a $0.49 per share dividend for the first quarter of 2014.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-KFY2013filed February 11, 2014Financial Statements
FY2013 against FY2012
| Line item | FY2013FY2012 | Change |
|---|---|---|
| Operating Expenses | $153.03M$135.49M | +12.9% |
| Operating Income | $265.68M$214.97M | +23.6% |
| Interest Expense | $100.38M$95.53M | +5.1% |
| Net Income | $172.52M$120.70M | +42.9% |
| EPS (Basic) | $1.47$1.12 | +31.2% |
| EPS (Diluted) | $1.46$1.12 | +30.4% |
| Shares Outstanding (Basic) | 117K107.59M | −99.9% |
| Shares Outstanding (Diluted) | 118K108.01M | −99.9% |
05—Questions
Frequently Asked Questions
What drove the increase in Omega's 2013 revenue?
Rental income rose $60.5 million to $375.1 million, mainly from new investments made in 2012 and 2013 and the full-year impact of the December 2012 Genesis transaction. Direct financing lease income of $5.2 million came from the November 2013 Ark transaction, and other investment income rose $4.1 million to $8.9 million, largely due to a $25 million mezzanine loan.
How concentrated is Omega's tenant base?
The filing states that New Ark Investment, Inc. was the only operator above 10% of total investments at 14%. Genesis HealthCare (13%) and CommuniCare (11%) each generated more than 10% of 2013 revenues. The filing notes that Medicare and Medicaid reimbursement changes could affect these operators' ability to meet obligations to Omega.
How did Omega fund its 2013 investments?
Omega sold approximately 5.5 million shares under its 2013 Equity Shelf Program at an average price of $30.87, generating gross proceeds of about $170.4 million. It also completed an October 2013 offering of 2.875 million shares at $30 per share, with net proceeds of about $84.6 million. Debt financing included net proceeds of $168 million on the 2012 Credit Facility and a $200 million term loan entered in December 2013.
What reimbursement risks does the filing identify for Omega's operators?
The filing describes the American Taxpayer Relief Act as designed to reduce Medicare payments to SNFs by an estimated $600 million over 2012 to 2022, and it notes sequestration cuts of 2% to Medicare providers effective March 1, 2013. It also describes Medicaid reimbursement reductions by many states and the Healthcare Reform Law's potential effects on operator payments. Management states it currently believes operators can absorb moderate rate reductions.
What is the outlook for general and administrative expense in 2014?
The filing says Omega expects somewhat higher general and administrative expense in 2014, primarily reflecting the impact of 2013 acquisitions and approximately $2.7 million of additional stock-based compensation expense tied to its new long-term incentive compensation program.
06—Continue